Fluconaz 150 (Fluconazole)

Regulatory Note: Fluconaz 150mg contains Fluconazole 150mg, a synthetic triazole antifungal. This is specifically the FDA-approved strength and dose for vaginal candidiasis — the single most common reason this medication is prescribed. The originator branded product, Diflucan (Pfizer), has held this specific single-dose indication for decades. Fluconaz 150mg is a generic formulation containing the identical active molecule. 

Fluconaz 150mg is an antifungal tablet containing Fluconazole 150mg, a member of the triazole class of antifungal drugs. Unlike the higher-strength Fluconaz tablets (100mg, 200mg, 400mg) used for multi-day treatment of oropharyngeal, esophageal, or systemic fungal infections, 150mg is specifically the FDA-approved single-dose strength for vaginal candidiasis — meaning this particular tablet is, in most cases, taken exactly once, not as part of a daily regimen. 

An important clarification the source content gets partially right but does not fully explain: It correctly notes that “oral administration of a single dose is the standard practice” for this strength, and that doctors “may prescribe additional doses” for recurrent infections — but it does not specify the actual evidence-based regimens for either scenario, which are detailed in the Dosage section below and represent genuinely useful clinical information for patients dealing with recurrent yeast infections. 

What is Fluconaz 150mg? 

Fluconaz 150mg is a tablet formulation of Fluconazole, a synthetic triazole antifungal with a broader spectrum of activity than earlier imidazole antifungals. Fluconazole is cleared primarily by the kidneys as unchanged drug, and has an elimination half-life of approximately 30 hours — a long duration that is precisely why a single 150mg dose can provide effective, sustained antifungal activity against uncomplicated vaginal candidiasis without needing repeat dosing. 

Vaginal candidiasis (commonly called a vaginal yeast infection) is most often caused by Candida albicans, though other Candida species (such as C. glabrata or C. tropicalis) can be responsible in a minority of cases and may respond less predictably to fluconazole, occasionally requiring alternative antifungal therapy. 

How Does Fluconaz 150mg Work? 

Mechanism of Action 

Fluconazole inhibits the fungal enzyme lanosterol 14α-demethylase (CYP51), which is required to convert lanosterol into ergosterol — the sterol that maintains the structural integrity of the fungal cell membrane. Blocking this step causes accumulation of abnormal sterol precursors, disrupting the fungal cell membrane and ultimately halting fungal growth and reproduction, allowing the infection to resolve. This matches the general description in the source content, though the specific enzyme target (CYP51) is worth naming, as it explains fluconazole’s selectivity for fungal cells over human ones (which rely on a related but distinct enzyme pathway for cholesterol synthesis). 

Uses of Fluconaz 150mg 

Primary Use: Vaginal Candidiasis 

Fluconaz 150mg is most commonly prescribed for uncomplicated vaginal candidiasis — a yeast infection causing itching, burning, redness, and abnormal (often thick, white, “cottage cheese-like”) vaginal discharge. Clinical trial data comparing treatment approaches found that oral fluconazole was highly effective: one randomized comparison of 150 women found clinical effectiveness rates of 80–92% with 6-day oral fluconazole dosing and 76–80% with single-dose fluconazole, both outperforming topical clotrimazole (58–72%) at both short- and long-term follow-up — supporting single-dose oral therapy as a genuinely effective, convenient option for uncomplicated infections. 

Other Fungal Infections 

While less common at this specific strength, fluconazole is also used (typically via other tablet strengths in combination or via multiple 150mg tablets) for oropharyngeal and esophageal candidiasis, systemic Candida infections, Candida urinary tract infections and peritonitis, and cryptococcal meningitis — each of which requires substantially different, multi-day dosing regimens covered in dedicated dosage guidance for those specific indications (see the Fluconaz 100mg/200mg/400mg guides for indication-specific regimens). 

Dosage and Administration of Fluconaz 150mg 

This is the section where the source content is most incomplete — it correctly notes single-dose administration and the possibility of “additional doses” for recurrent infections, but does not specify what those regimens actually are. The evidence-based regimens are: 

 

Clinical Scenario	FDA-Referenced / Evidence-Based Regimen
Uncomplicated vaginal candidiasis	150 mg as a SINGLE oral dose — no repeat dosing needed
Severe or complicated vaginal candidiasis	Two 150 mg doses, given 3 days apart (Day 1 and Day 4) — superior cure rates vs. single dose
Recurrent vulvovaginal candidiasis (RVVC) — induction	150 mg every 3 days for 3 total doses, then move to suppressive phase
Recurrent vulvovaginal candidiasis — suppressive/maintenance	150 mg once weekly for 6 months
Oropharyngeal candidiasis (using 150mg tablets)	200 mg-equivalent Day 1 loading (e.g., via combined tablets), then 100mg-equivalent daily — 150mg strength less commonly used for this indication
Renal impairment — single-dose vaginal therapy	No dose adjustment required
Renal impairment — repeated/suppressive dosing	Dose interval or amount may need adjustment based on creatinine clearance

How to Take Fluconaz 150mg 

• Take orally, as a single dose, with or without food — food does not significantly affect absorption 
• For uncomplicated infections, no repeat dose is needed — one tablet is the complete treatment 
• If symptoms have not improved within several days (typically by day 3), or if symptoms worsen, contact your healthcare provider — this may indicate a non-Candida cause, a resistant species, or a need for the extended regimen 
• For recurrent infections (defined as 4 or more episodes in a year), a structured induction and maintenance regimen — not repeated single doses taken reactively — provides the best outcomes (see table above) 

Missed Dose 

Because Fluconaz 150mg is typically a single-dose treatment, the concept of a “missed dose” does not usually apply. For patients on a weekly suppressive regimen, a missed weekly dose should be taken as soon as remembered, without doubling up. 

Overdose 

Fluconazole overdose has historically been associated with hallucinations and paranoid behaviour in reported cases. Seek medical attention immediately if an overdose is suspected.

Side Effects of Fluconaz 150mg 

Common Side Effects 

• Nausea, abdominal pain, or diarrhoea 
• Headache 
• Dizziness 
• Altered taste sensation 

A notable finding from the comparative clinical trial cited above: no treatment-related side effects were reported in any of the three treatment groups studied (6-day oral, single-dose oral, or topical clotrimazole), suggesting a generally favourable single-dose tolerability profile for this specific indication and dose. 

Serious Side Effects — Seek Immediate Medical Attention 

• Severe skin reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported with fluconazole use generally. Any severe rash, blistering, or skin peeling requires immediate medical evaluation. 
• Cardiac arrhythmia: Fluconazole can prolong the QT interval, particularly relevant if combined with other QT-prolonging medications (see Drug Interactions below). Palpitations, fainting, or irregular heartbeat warrant urgent evaluation. 
• Liver injury: Yellowing of the skin or eyes, dark urine, or significant abdominal pain may indicate hepatotoxicity, even though this is more commonly associated with higher, repeated dosing than a single 150mg dose. 
• Allergic reaction: Swelling of the face, lips, tongue, or throat, or difficulty breathing, requires emergency treatment. 

Drug Interactions 

The source content mentions interactions only in general terms. Fluconazole is a moderate CYP3A4/CYP2C9 inhibitor and a strong CYP2C19 inhibitor, and this inhibitory effect is dose-dependent — becoming most clinically significant at daily doses around 200mg or higher. A single 150mg dose carries a lower but not zero interaction risk compared to sustained daily dosing, which is an important nuance for patients taking this specific strength who may also be on other medications: 

 

Drug	Clinical Action	Mechanism / Risk
Cisapride, terfenadine, astemizole, pimozide, quinidine	ABSOLUTE CONTRAINDICATION	Serious cardiac arrhythmias (torsades de pointes) via QT prolongation
Erythromycin	ABSOLUTE CONTRAINDICATION	Combined enzyme inhibition significantly raises arrhythmia risk
Warfarin	Monitor INR closely; reduce warfarin dose gradually	CYP2C9/CYP3A4 inhibition increases prothrombin time and bleeding risk
Phenytoin, carbamazepine	Monitor for toxicity/neurotoxicity	Increased antiepileptic drug levels via CYP inhibition
Cyclosporine, tacrolimus	Monitor drug levels closely	Increased immunosuppressant plasma concentration — toxicity risk
Statins (atorvastatin, simvastatin)	Monitor for myopathy/rhabdomyolysis	Reduced statin metabolism via CYP3A4/CYP2C9 inhibition
Sulfonylureas (glipizide, glyburide)	Monitor blood glucose — hypoglycaemia risk	Reduced clearance of oral hypoglycaemic agents
Oral contraceptives	Be aware; generally no dose change needed	Fluconazole 150mg single dose has smaller effect than daily 200mg dosing on hormone levels
Rifampin (rifampicin)	May reduce fluconazole efficacy	Rifampin induces fluconazole metabolism, lowering its plasma levels

Because fluconazole’s enzyme-inhibiting effect persists for 4 to 5 days after the drug is taken (due to its long ~30-hour half-life), the interaction risk from even a single 150mg dose remains relevant for several days afterward, not just on the day the tablet is taken — a detail the source content omits entirely. 

Pregnancy — Important Nuance for This Specific Dose 

This is directly relevant to Fluconaz 150mg, since a single 150mg dose is the exact regimen studied in the pregnancy safety research discussed below — the source content’s general advice to “discuss with your doctor” omits substantial, specific findings that inform that conversation: 

• Miscarriage signal at this exact dose: A large Danish nationwide cohort study (published in JAMA) found that oral fluconazole exposure during pregnancy — most commonly one or two 150mg doses, precisely this product’s standard regimen — was associated with a statistically significant increased risk of spontaneous abortion compared to unexposed women or those using topical antifungals. 

• Regulatory response: The FDA reviewed this data and advised cautious prescribing of oral fluconazole in pregnancy, while noting that available evidence does not provide definitive proof of increased birth defect risk specifically from a single 150mg dose (as distinct from high-dose, prolonged use, which carries separately documented embryopathy risk). 

• Current first-line guidance: The CDC recommends topical antifungal treatments (such as clotrimazole or miconazole) as the preferred option for pregnant women with vaginal yeast infections, reserving oral fluconazole — including this 150mg single-dose product — for situations where topical treatment has failed or is not suitable, following informed discussion of this evidence. 

 

Precautions and Warnings 

Allergy 

Do not take Fluconaz 150mg if you have a known hypersensitivity to fluconazole or other azole antifungal medications. 

Liver Disease 

Use with caution in patients with pre-existing liver disease. While hepatotoxicity is more strongly associated with higher, repeated dosing, disclosure of any liver condition to your prescriber remains important. 

Kidney Disease 

No dose adjustment is needed for the single-dose vaginal candidiasis regimen, even in patients with renal impairment — this is a specific, useful point of reassurance the source content does not mention. Dose adjustment becomes relevant only for repeated or suppressive dosing regimens. 

Recurrent Infections — When to Seek Further Evaluation 

If yeast infections recur frequently (4 or more times per year), this may indicate an underlying condition such as poorly controlled diabetes, immune suppression, or infection with a less fluconazole-responsive Candida species. Rather than repeatedly self-treating with single doses, patients should be evaluated by a healthcare provider for the structured induction/maintenance regimen described above or for alternative diagnosis. 

Breastfeeding 

Fluconazole is excreted into breast milk. Discuss the risks and benefits of continued breastfeeding with your healthcare provider if fluconazole therapy is needed. 

 Storage Instructions 

• Store at room temperature, away from moisture and direct sunlight 
• Keep out of reach of children and pets 
• Check the expiry date before use 

Frequently Asked Questions (FAQs) 

What is Fluconaz 150mg used for? 

Fluconaz 150mg is primarily used for uncomplicated vaginal candidiasis (yeast infection), taken as a single oral dose. It is not typically the strength used for oral thrush, esophageal candidiasis, or systemic fungal infections, which use different multi-day dosing regimens at other tablet strengths. 

Do I need to take more than one Fluconaz 150mg tablet? 

For an uncomplicated infection, no — one tablet is the complete treatment. Repeat dosing is only used for severe/complicated infections (two doses 3 days apart) or recurrent infections (a structured induction and 6-month weekly maintenance regimen) — not for routine reactive re-dosing. 

How quickly does Fluconaz 150mg work? 

Many patients notice symptom relief within 24 to 72 hours, consistent with clinical trial data. If there is no improvement within a few days, contact your healthcare provider, as this may suggest a different cause or a less responsive Candida species. 

Is Fluconaz 150mg safe during pregnancy? 

This requires careful, informed discussion with your doctor. A large study found an increased miscarriage risk specifically associated with the one-or-two 150mg dose pattern typical of this product. Current guidance favours topical antifungal treatment first-line during pregnancy, reserving oral fluconazole for situations where it is specifically needed. 

Can men take Fluconaz 150mg? 

Yes — fluconazole is effective for fungal infections in men as well as women, including certain forms of candidiasis (such as balanitis, a Candida infection of the penis) when appropriately diagnosed and prescribed by a healthcare provider. 

Do I need a kidney function test before taking Fluconaz 150mg? 

Not for the single-dose regimen — no dose adjustment is required for vaginal candidiasis therapy regardless of renal function. Kidney function becomes relevant only if repeated or suppressive dosing is prescribed. 

Medical Disclaimer 

All information in this guide is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Fluconaz 150mg is a prescription medication in most markets and should be used under the guidance of a licensed healthcare provider. Never self-medicate repeatedly for recurrent symptoms without medical evaluation. In an emergency, contact local emergency services immediately. Report suspected adverse effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.